Holen Sie sich die Stockscreener-App
1.74
4.82%
0.08
Handel nachbörslich:
1.74
Schlusskurs vom Vortag:
$1.66
Offen:
$1.65
24-Stunden-Volumen:
362.32K
Relative Volume:
0.59
Marktkapitalisierung:
$70.90M
Einnahmen:
$68.68M
Nettoeinkommen (Verlust:
$-60.84M
KGV:
-1.0875
EPS:
-1.6
Netto-Cashflow:
$-38.42M
1W Leistung:
-1.14%
1M Leistung:
+5.45%
6M Leistung:
-79.93%
1J Leistung:
-73.64%
1-Tages-Spanne:
$1.5901
$1.76
1-Wochen-Bereich:
$1.5901
$1.85
52-Wochen-Spanne:
$1.47
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Firmenname
Pulmonx Corp
Sektor
Branche
Telefon
650-364-0400
Adresse
700 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie LUNG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.74 | 70.49M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Eingeleitet | D. Boral Capital | Buy |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-04 | Eingeleitet | Lake Street | Buy |
| 2024-02-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Neutral |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-10-26 | Eingeleitet | BofA Securities | Buy |
| 2020-10-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-10-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Eingeleitet | Stifel | Buy |
| 2020-10-26 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Pulmonx Corp Aktie (LUNG) Neueste Nachrichten
Will breakout in Pulmonx Corporation lead to full recoveryJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Backtesting results for Pulmonx Corporation trading strategiesMarket Growth Summary & Reliable Breakout Stock Forecasts - Newser
How to build a custom watchlist for Pulmonx CorporationWeekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Using data tools to time your Pulmonx Corporation exitJuly 2025 Institutional & Verified Short-Term Plans - Newser
How to track smart money flows in Pulmonx Corporation2025 Market Overview & Verified Swing Trading Watchlists - Newser
Using R and stats models for Pulmonx Corporation forecasting2025 Performance Recap & Community Verified Watchlist Alerts - Newser
What data driven models say about Pulmonx Corporation’s future2025 Geopolitical Influence & Reliable Volume Spike Alerts - Newser
Pattern recognition hints at Pulmonx Corporation upsideJuly 2025 Decliners & Accurate Technical Buy Alerts - Newser
What Fibonacci levels say about Pulmonx Corporation reboundJuly 2025 Retail & Growth Focused Stock Reports - Newser
Real time pattern detection on Pulmonx Corporation stock2025 Price Action Summary & Breakout Confirmation Alerts - Newser
What are the future prospects of Pulmonx CorporationMarket Volume Report & Long-Term Safe Investment Plans - khodrobank.com
Chart based analysis of Pulmonx Corporation trends2025 Historical Comparison & Entry Point Strategy Guides - Newser
Can trapped investors hope for a rebound in Pulmonx Corporation2025 Price Momentum & Consistent Growth Stock Picks - Newser
Does Pulmonx Corporation fit your quant trading model2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Pulmonx CorporationCPI Data & Weekly Return Optimization Plans - Newser
Will Pulmonx Corporation bounce back from current supportOptions Play & Daily Growth Stock Tips - Newser
Will Pulmonx Corporation stock recover after recent dropProfit Target & Consistent Return Investment Signals - Newser
Is Pulmonx Corporation meeting your algorithmic filter criteriaTrade Performance Summary & AI Optimized Trade Strategies - Newser
Trend analysis for Pulmonx Corporation this weekQuarterly Trade Review & Technical Pattern Based Buy Signals - Newser
Is it time to cut losses on Pulmonx CorporationVolume Spike & Daily Volume Surge Signals - Newser
How to escape a deep drawdown in Pulmonx Corporation2025 Year in Review & Technical Confirmation Trade Alerts - Newser
Real time alert setup for Pulmonx Corporation performanceTrade Ideas & Stepwise Trade Signal Implementation - Newser
Pulmonx (NASDAQ:LUNG) Upgraded by Wall Street Zen to Hold Rating - Defense World
Applying big data sentiment scoring on Pulmonx CorporationJuly 2025 Levels & Reliable Entry Point Alerts - Newser
Published on: 2025-08-29 19:26:58 - Newser
Finanzdaten der Pulmonx Corp-Aktie (LUNG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pulmonx Corp-Aktie (LUNG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Joshi Mehul | Chief Financial Officer & PAO |
Sep 02 '25 |
Sale |
1.60 |
7,936 |
12,698 |
208,489 |
| Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER |
Sep 02 '25 |
Sale |
1.60 |
6,543 |
10,469 |
379,788 |
| Lehman David Aaron | GENERAL COUNSEL |
Sep 02 '25 |
Sale |
1.60 |
9,769 |
15,630 |
263,270 |
| Ferrari Richard | Director |
Jun 12 '25 |
Sale |
3.16 |
8,000 |
25,280 |
87,024 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):